Healthcare - Biotechnology - NASDAQ - US
$ 0.17
-5.56 %
$ 11.1 M
Market Cap
-0.11
P/E
Price Target
Average
194.12%
Revenue Forecast
Estimate
120.45%
EBIT
Estimate
42.46%
Net Income
Estimate
35.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lyra Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for LYRA of $0.5 , with forecasts ranging from a low of $0.5 to a high of $0.5 .
LYRA Lowest Price Target
Wall Street Target
0.5 USD
194.12%
LYRA Average Price Target
Wall Street Target
0.5 USD
194.12%
LYRA Highest Price Target
Wall Street Target
0.5 USD
194.12%
REVENUE FORECAST
Revenue Forecast Chart LYRA
EBIT FORECAST
EBIT Forecast Chart LYRA
NET INCOME FORECAST
Net Income Chart LYRA